Stock Report

Download full stock data and analysis for free Last Updated: 29-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

HUTCHMED (China) - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$13.32

up-down-arrow $-0.48 (-3.48%)

As on 28-Oct-2026 16:00EDT

Market cap

info icon

$2,496 Mln

Revenue (TTM)

info icon

$549 Mln

P/E Ratio

info icon

143.6

P/B Ratio

info icon

2.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 0.22 -8.81 -10.16 14.52
EBIT 0.00 124.73 -76.55 18.16 13.31
Net Profit 0.00 -96.50 -96.17 37.64 19.21
EPS 0.00 -96.50 -96.17 35.97 15.16
Book Value -- -- 62.88 25.20 16.19
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -4.90-28.50-6.33-9.95-6.94
Net Margin info ----3.26----
Return on equity info 21.99-1.141.4345.865.06
Return on Capital info 20.10-1.64--41.924.53
Return on Assets info 13.98-1.330.6630.272.95
Debt to Equity (x) info ----0.000.080.12

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
41.92
4.53
13.86
-43.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

1.43

Higher than Peers by 19.22

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
1.43
45.86
5.06
15.03
-45.18
Peer Median
-17.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

0.66

Higher than Peers by 13.14

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
0.66
30.27
2.95
8.73
-30.04
Peer Median
-12.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-6.33

Higher than Peers by 46.87

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
-6.33
-9.95
-6.94
2.19
-84.43
Peer Median
-53.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

3.26

Higher than Peers by 63.51

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
3.26
83.30
5.99
12.03
-84.62
Peer Median
-60.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-8.81

Lower than Peers by 30.99

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
-8.81
-0.13
-0.25
0.97
0.20
Peer Median
22.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-76.55

Lower than Peers by 89.23

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
-76.55
-25.22
-337.85
105.10
-132.97
Peer Median
12.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-96.17

Lower than Peers by 107.08

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
-96.17
1,114.23
-62.56
127.93
-85.38
Peer Median
10.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-96.17

Lower than Peers by 125.09

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
-96.17
11.14
-0.63
1.28
-0.88
Peer Median
28.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

2.54

Higher than Peers by 1.14

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
2.54
--
--
--
--
Peer Median
1.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
0.08
0.12
0.12
0.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
0.02
0.02
0.03
0.05
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

5.64

Higher than Peers by 0.99

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
5.64
4.96
2.83
2.72
2.37
Peer Median
4.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

5.50

Higher than Peers by 0.85

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
5.50
4.83
2.70
2.60
2.21
Peer Median
4.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
-19.05
-15.22
24.21
-552.17
Peer Median
0.71
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

21.41

Lower than Peers by 3.78

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
21.41
26.88
26.62
17.95
29.72
Peer Median
25.19
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.20

Lower than Peers by 0.06

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
0.20
0.36
0.49
0.73
0.36
Peer Median
0.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
104.79
92.21
60.41
117.55
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
49.57
52.88
50.80
54.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
47.68
41.42
51.04
65.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
106.67
103.67
60.17
105.89
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

143.60

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
143.60
5.08
66.70
30.64
-6.92
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.25

Lower than Peers by 1.40

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
2.25
1.88
3.31
4.23
4.09
Peer Median
3.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

38.51

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
38.51
-25.56
-56.44
86.04
-5.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

2,496

Higher than Peers by 2,374

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
HUTCHMED (China) - ADR
2,496
--
--
--
--
Peer Median
122
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds